Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation

An aqueous formulation comprising:

• about 25 mg/ml of an anti-vascular endothelial growth factor (VEGF) antibody;
• about 20 mM histidine or succinate buffer;
• about 85 mg/mL sucrose;
• about 0.2 mg/ml polysorbate 80;
• about 0.05 mg/ml EDTA;
• wherein the antibody comprises a heavy chain variable region comprising the amino acid sequence of SEQ ID NO:
• 7, and a light chain variable region comprising the amino acid sequence of SEQ ID NO:
• 8;
• and
• wherein the formulation has pH at about 5.5 or 5.8.